Breast cancer is a heterogeneous disease classified into distinct subtypes based on pathologic status of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) combined with molecular examination of other markers1–4. Here, ERBB2 is linked to breast cancer.